Minichromosome maintenance protein 3 is a candidate proliferation marker in papillary thyroid carcinoma

Experimental and Molecular Pathology

Volumn 88, Issue 1, 2010, Pages 138-142

  Lee, Youn Soo ^a   Ha, Seon Ah ^b   Kim, Hae Joo ^b   Shin, Seung Min ^b   Kim, Hyun Kee ^b   Kim, Sanghee ^b   Kang, Chang Suk ^a   Lee, Kyo Young ^a   Hong, Oak Kee ^c   Lee, Seung Hwan ^c   Kwon, Hyuk Sang ^c   Cha, Bong Yun ^c   Kim, Jin Woo ^b,c  

^a Research Institute of Medical Science ^*

^b Molecular Genetic Laboratory

^c The Catholic University of Korea   (South Korea)

Author keywords

MCM3; Papillary thyroid carcinoma; Proliferation marker

Indexed keywords

KI 67 ANTIGEN; MINICHROMOSOME MAINTENANCE PROTEIN 3;

ADULT; AGED; ARTICLE; CANCER INVASION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; RELIABILITY; THYROID PAPILLARY CARCINOMA; TUMOR GROWTH; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; BLOTTING, WESTERN; CARCINOMA, PAPILLARY, FOLLICULAR; CELL CYCLE PROTEINS; CELL PROLIFERATION; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; NUCLEAR PROTEINS; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 74749102178     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2009.09.015     Document Type: Article

References (27)

1. Chevalier S., and Blow J.J. Cell cycle control of replication initiation in eukaryotes. Curr. Opin. Cell Biol. 8 (1996) 815-821
2. Erickson L.A., Jin L., Wollan P.C., Thompson G.B., van Heerden J., and Lloyd R.V. Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors. Modern Pathol. 11 (1998) 169-174
3. Freeman A., Morris L.S., Mills A.D., Stoeber K., Laskey R.A., Williams G.H., and Coleman N. Minichromosome maintenance proteins as biological markers of dysplasia and malignancy. Clin. Cancer Res. 5 (1999) 2121-2132
4. Gerdes J., Dallenbach F., Lennert K., Lemke H., and Stein H. Growth fractions in malignant non-Hodgkin's lymphomas (NHL) as determined in situ with the monoclonal antibody Ki-67. Hematol. Oncol. 2 (1984) 365-371
5. Gonzalez M.A., Pinder S.E., Callagy G., Vowler S.L., Morris L.S., Bird K., Bell J.A., Laskey R.A., and Coleman N. Minichromosome maintenance protein 2 is a strong independent prognostic marker in breast cancer. J. Clin. Oncol. 21 (2003) 4306-4313
6. Guida T., Salvatore G., Faviana P., Giannini R., Garcia-Rostan G., Provitera L., Basolo F., Fusco A., Carlomagno F., and Santoro M. Mitogenic effects of the up-regulation of minichromosome maintenance proteins in anaplastic thyroid carcinoma. J. Clin. Endocr. Metab. 90 (2005) 4703-4709
7. Ha S.A., Shin S.M., Namkoong H., Lee H., Cho G.W., Hur S.Y., Kim T.E., and Kim J.W. Cancer-associated expression of minichromosome maintenance 3 gene in several human cancers and its involvement in tumorigenesis. Clin. Cancer Res. 10 (2004) 8386-8395
8. Hay I.D., Bergstralh E.J., Goellner J.R., Ebersold J.R., and Grant C.S. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 114 (1993) 1050-1057
9. Hiraiwa A., Fujita M., Nagasaka T., Adachi A., Ohashi M., and Ishibashi M. Immunolocalization of hCDC47 protein in normal and neoplastic human tissues and its relation to growth. Int. J. Cancer 74 (1997) 180-184
10. Jansen R.L., Hupperets P.S., Arends J.W., Joosten-Achjanie S.R., Volovics A., Schouten H.C., and Hillen H.F. MIB-1 labelling index is an independent prognostic marker in primary breast cancer. Brit. J. Cancer 78 (1998) 460-465
11. Kato H., Miyazaki T., Fukai Y., Nakajima M., Sohda M., Takita J., Masuda N., Fukuchi M., Manda R., Ojima H., Tsukada K., Asao T., and Kuwano H. A new proliferation marker, minichromosome maintenance protein 2, is associated with tumor aggressiveness in esophageal squamous cell carcinoma. J. Surg. Oncol. 84 (2003) 24-30
12. Katoh R., Bray C.E., Suzuki K., Komiyama A., Hemmi A., Kawaoi A., Oyama T., Sugai T., and Sasou S. Growth activity in hyperplastic and neoplastic human thyroid determined by an immunohistochemical staining procedure using monoclonal antibody MIB-1. Human Pathol. 26 (1995) 139-146
13. Kjellman P., Wallin G., Hoog A., Auer G., Larsson C., and Zedenius J. MIB-1 index in thyroid tumors: a predictor of the clinical course in papillary thyroid carcinoma. Thyroid 13 (2003) 371-380
14. Korean Ministry of Health and Welfare. Annual report of the Korea Central Cancer Registry. Seoul (2004) 2004
15. MacCallum D.E., and Hall P.A. The location of pKi67 in the outer dense fibrillary compartment of the nucleolus points to a role in ribosome biogenesis during the cell division cycle. J. Pathol. 190 (2000) 537-544
16. Madine M.A., Swietlik M., Pelizon C., Romanowski P., Mills A.D., and Laskey R.A. The roles of the MCM, ORC, and Cdc6 proteins in determining the replication competence of chromatin in quiescent cells. J. Struct. Biol. 129 (2000) 198-210
17. Mashal R.D., Lester S., Corless C., Richie J.P., Chandra R., Propert K.J., and Dutta A. Expression of cell cycle-regulated proteins in prostate cancer. Cancer Res. 56 (1996) 4159-4163
18. Mehrotra P., Gonzalez M.A., Johnson S.J., Coleman N., Wilson J.A., Davies B.R., and Lennard T.W. Mcm-2 and Ki-67 have limited potential in preoperative diagnosis of thyroid malignancy. Laryngoscope 116 (2006) 1434-1438
19. Musahl C., Holthoff H.P., Lesch R., and Knippers R. Stability of the replicative MCM3 protein in proliferating and differentiating human cells. Exp. Cell Res. 24 (1998) 260-264
20. Perry A., Stafford S.L., Scheithauer B.W., Suman V.J., and Lohse C.M. The prognostic significance of MIB-1, p53, and DNA flow cytometry in completely resected primary meningiomas. Cancer 82 (1998) 2262-2269
21. Ramnath N., Hernandez F.J., Tan D.F., Huberman J.A., Natarajan N., Beck A.F., Hyland A., Todorov I.T., Brooks J.S., and Bepler G. MCM2 is an independent predictor of survival in patients with non-small-cell lung cancer. J. Clin. Oncol. 19 (2001) 4259-4266
22. Rodins K., Cheale M., Coleman N., and Fox S.B. Minichromosome maintenance protein 2 expression in normal kidney and renal cell carcinomas: relationship to tumor dormancy and potential clinical utility. Clin. Cancer Res. 8 (2002) 1075-1081
23. Siironen P., Louhimo J., Nordling S., Ristimaki A., Maenpaa H., Haapiainen R., and Haglund C. Prognostic factors in papillary thyroid cancer: an evaluation of 601 consecutive patients. Tumour Biol. 26 (2005) 57-64
24. Stoeber K., Swinn R., Prevost A.T., de Clive-Lowe P., Halsall I., Dilworth S.M., Marr J., Turner W.H., Bullock N., Doble A., Hales C.N., and Williams G.H. Diagnosis of genito-urinary tract cancer by detection of minichromosome maintenance 5 protein in urine sediments. J. Natl. Cancer Inst. 94 (2002) 1071-1079
25. Szelachowska J., Dziegiel P., Jelen-Krzeszezka J., Jelen M., Matkowski R., Pomiecko A., Spytkowska B., Jagas M., Giesterek I., and Kornafel J. Mcm-2 protein expression predicts prognosis better than Ki-67 antigen in oral cavity squamocellular carcinoma. Anticancer Res. 26 (2006) 2473-2478
26. Timler D., Tazbir J., Matejkowska M., Gosek A., Czyz W., and Brzezinski J. Expression of proteins: D1 cyclin and Ki-67 in papillary thyroid carcinomas. Folia Histochem. Cytobiol. 39 (2001) 201-202
27. Tye B.K. MCM proteins in DNA replication. Ann. Rev. Biochem. 68 (1999) 649-686